Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0356920100580030244
Korean Journal of Anesthesiology
2010 Volume.58 No. 3 p.244 ~ p.248
The influence of age and gender on remifentanil EC50 for preventing rocuronium induced withdrawal movements
Park So-Jin

Park Hye-Jin
Choi Ju-Youn
Kang Hyo-Seok
Choi Hong-Seok
Abstract
Background: Rocuronium-induced withdrawal movements can be harmful to patients during the induction period. Remifentanil has been reported to reduce these movements effectively. In this study, we determined the EC50 of remifentanil for the prevention of rocuronium induced withdrawal movements in male, female, old and child group.

Methods: We included patients scheduled for general anesthesia and assigned them into 4 groups depending on their age and gender: male group (20-60 yr), female group (20-60 yr), old group (>65 yr) and child group (6-12 yr). Remifentanil was administered by target controlled infusion. Propofol 2 mg/kg was then administered after equilibration between the effect and plasma concentration of remifentanil was reached. After loss of consciousness, rocuronium 0.6 mg/kg was administered. Patient¡¯s response to the rocuronium was graded using a 4 point scale in a blinded manner. The EC50 of remifentanil for preventing rocuronium induced withdrawal movements was determined using Dixon¡¯s up-and -down method.

Results: The EC50 of remifentanil for preventing rocuronium induced withdrawal movements was 1.8 ¡¾ 0.5 ng/ml [95% confidence interval 1.3-2.2] in the male group, 2.3 ¡¾ 1.0 ng/ml [1.3-3.2] in the female group, 0.5 ¡¾ 0.4 ng/ml [0.2-0.8] in the old group and 2.8 ¡¾ 0.8 ng/ml [2.1-3.5] in the child group.

Conclusions: The EC50 of remifentanil for preventing rocuronium induced withdrawal movements was lowest in the elderly and higher in children than male adult patients. No difference in the EC50 of remifentanil was seen between male and female adult patients.
KEYWORD
Remifentanil, Rocuronium, Withdrawal movements
FullTexts / Linksout information
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø